Singapore May Tighten E-Cigarette Rules as Surge Detected in Products Laced with Anesthetic Etomidate

Jul.15.2025
Singapore May Tighten E-Cigarette Rules as Surge Detected in Products Laced with Anesthetic Etomidate
Singapore plans to tighten vaping laws after detecting 28 etomidate-laced e-cigarette cases in H1 2025—nearly triple 2024’s total. Despite the 2018 ban, S$41 million worth of products were seized from Jan 2024 to Mar 2025, and a UN report shows rising etomidate e-cigarette use across East and Southeast Asia.

Key points:

 

·The number of e-cigarettes containing drugs in Singapore has surged, potentially leading to legislative regulations.

 

· Between January and June 2025, there were 28 cases of e-cigarettes containing anaesthetics found. A 13-year-old girl exhibited abnormal behavior after using an e-cigarette with anaesthetics.

 

· Singapore is enhancing market supervision and education on e-cigarettes.

 


【2Firsts News Flash】According to a report by Borneo Bulletin on July 14th, Singapore may tighten its current regulations on e-cigarettes, as the country has seen a continuous increase in the number of e-cigarettes containing controlled substances, including the anesthetic propofol. This trend has raised concerns among the government and may lead to stricter regulations.

 

The Ministry of Health and the Ministry of Home Affairs in Singapore said in a joint statement that they are currently discussing whether there is a need to strengthen existing regulations to curb this escalating trend. According to data from the Singapore Health Science Authority, in the first half of 2025, the country reported 28 cases of e-cigarettes containing ethylene glycol, nearly three times the 10 cases reported in 2024.

 

Despite the ban on e-cigarettes in Singapore as early as February 2018, authorities have confiscated e-cigarettes and related accessories worth over 41 million Singapore dollars (about 32.03 million US dollars) from January 2024 to March 2025. Officials emphasize that the emergence of e-cigarettes containing psychotropic drugs is similar to this trend, and this phenomenon is currently unfolding in Singapore.

 

A recent case involves a 13-year-old girl who exhibited erratic behavior after using an e-cigarette outside a state courthouse. The investigation found that the "Kpod" e-cigarette she used contained the anesthetic drug ketamine. Subsequently, a 25-year-old man who sold the e-cigarette to the girl was arrested, with both him and his wife assisting in the investigation.

 

The authorities have warned that the use of propofol is a controlled substance under the Poison Act and can only be used in a medical environment. Inhaling it through e-cigarettes can lead to serious health risks, including involuntary muscle spasms, seizures, mental confusion, and physical dependency.

 

As part of ongoing law enforcement efforts, the Health Sciences Authority has ramped up monitoring of online platforms, physical hotspots, and public areas. It is also collaborating with institutions such as the Singapore Police Force, Immigration & Checkpoints Authority, and National Environment Agency. Additionally, the Health Promotion Board is working with the Ministry of Education to enhance education on the dangers of e-cigarettes for students, and supporting relevant users through the "I Quit" program.

 

The government has reiterated its commitment to ramp up enforcement against individuals who import, sell, possess, or use e-cigarettes containing harmful substances. Currently, in Singapore, individuals can be fined up to 2,000 Singapore dollars (approximately 1,560 US dollars) for possessing or using e-cigarettes, while importers or distributors face fines of up to 10,000 Singapore dollars (approximately 7,813 US dollars), six months in prison, or both penalties.

 

The phenomenon of drug-containing e-cigarettes in Malaysia has also raised concerns, with Malaysian authorities stating that 65% of the e-liquid seized since 2023 contains banned synthetic substances. The United Nations Office on Drugs and Crime also noted in a report in May that synthetic drug e-cigarettes, including those containing methamphetamine, are on the rise in the detection in East Asia and Southeast Asia.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | Japan Tobacco Expands Nordic Spirit Nicotine Pouch Range to Eight SKUs in Japan, Launches Melon Variant and Broadens Mint Retail Distribution
Product | Japan Tobacco Expands Nordic Spirit Nicotine Pouch Range to Eight SKUs in Japan, Launches Melon Variant and Broadens Mint Retail Distribution
Japan Tobacco Inc. (JT) launched Nordic Spirit Rich Melon Medium through selected tobacco retailers in Japan on November 2, 2026, while expanding physical retail distribution for three existing mint products previously sold through the CLUB JT online store. The melon launch brings Nordic Spirit's Japanese portfolio to eight SKUs. All four products are manufactured in Sweden, contain a standard 14 pouches per can and retail for ¥500 including tax. Since introducing Nordic Spirit in Japan in March, JT has expanded the brand's product lineup and distribution through its online store, convenience stores and selected tobacco retailers.
product
Nov.04
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
How Investors Are Repricing the Global Tobacco Industry as Nicotine Markets Shift
How Investors Are Repricing the Global Tobacco Industry as Nicotine Markets Shift
How are investors reassessing the global tobacco industry as nicotine markets evolve? In an interview with 2Firsts, Charlie Chen, Head of Research at CCB International Securities, forecasts annual growth of 30–50% for nicotine pouches, outpacing vaping and heated tobacco. He examines how regulatory enforcement, shifting market shares and new business models are influencing company valuations. The report also explores differences between multinational tobacco groups and Chinese companies, drawing on insights from the New Approaches Summit on profitability, investment strategies and industry consolidation.
Nov.11
White House Pulls Heidi Overton's FDA Nomination as Vaccine, Abortion Pill and Vaping Disputes Fuel Senate Opposition
White House Pulls Heidi Overton's FDA Nomination as Vaccine, Abortion Pill and Vaping Disputes Fuel Senate Opposition
The White House withdrew Heidi Overton's nomination to lead the U.S. Food and Drug Administration (FDA) on November 17, 2026, a day before a scheduled Senate committee vote. Overton faced questions from Republican and Democratic senators over vaccines, abortion medication and flavored nicotine products. In May, the FDA granted its first marketing authorizations for non-tobacco, non-menthol e-cigarette flavors, including mango and blueberry pods from Glas. Republican Senator Susan Collins challenged recent authorizations for flavored vaping and nicotine pouch products during Overton's September confirmation hearing. The FDA remains under Acting Commissioner Kyle Diamantas.
FDA
Nov.18
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06
PMI Pushes Smoke-Free Business in Latin America as Argentina Lifts Heated Tobacco Ban, Mexico City Share Tops 7%
PMI Pushes Smoke-Free Business in Latin America as Argentina Lifts Heated Tobacco Ban, Mexico City Share Tops 7%
Philip Morris International (PMI) showcased IQOS heated tobacco systems and nicotine pouch products at Technovation 2026 in Buenos Aires on October 7–8, presenting research on consumer attitudes, regulatory developments and illicit cigarette trade across Latin America. PMI Chief Global Growth Officer Stefano Volpetti said smoke-free products accounted for more than 7% of the Mexico City market. Argentina repealed its heated tobacco ban in May 2026 and introduced registration requirements for tobacco and nicotine products, while local media reported nicotine pouch sales in Mendoza. A PMI-commissioned survey found that only 8% of respondents across four Latin American countries were familiar with nicotine pouches. A separate KPMG study estimated illicit cigarette consumption at 77 billion sticks across 11 markets in Latin America and Canada in 2025.
PMI
Oct.13